Algentech Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Algentech General Information

Description

Developer of plant gene-editing technology designed for industrial and research applications. The company's proprietary technologies form unique tools for the precise engineering of nuclear and organelle genomes, enabling agriculture organizations to avoid nuclear transgene insertion and generation of cytoplasmic male sterility lines.

Contact Information

Website
www.algentech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4 rue Pierre Fontaine
  • 91058 Evry
  • France
+33 06
Primary Industry
Biotechnology
Other Industries
Other Commercial Services
Vertical(s)
Life Sciences
Corporate Office
  • 4 rue Pierre Fontaine
  • 91058 Evry
  • France
+33 06

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Algentech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private Completed Generating Revenue
6. Later Stage VC 11-Oct-2022 Completed Generating Revenue
5. Later Stage VC 21-Oct-2020 Completed Generating Revenue
4. Later Stage VC 09-May-2018 Completed Generating Revenue
3. Later Stage VC 02-Mar-2018 Completed Generating Revenue
2. Angel (individual) 01-Jul-2012 $251K $251K Completed Startup
1. Seed Round 01-Jan-2010 Completed Startup
To view Algentech’s complete valuation and funding history, request access »

Algentech Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 300 $0.984807 $1477.21 $1477.21 1x $1477.21 6.74%
Ordinary 135 $0.984807 $1349.19 $1349.19 1x $1349.19 3.03%
To view Algentech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Algentech Patents

  • 67

    Total Documents Applications and Grants

  • Total Patents Families

  • 40

    Granted

  • 11

    Pending

  • Expiring in next 12 mo

Algentech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3802808-A1 Gene targeting Pending 01-Jun-2018
CA-3102072-A1 Gene targeting Pending 01-Jun-2018
EP-3802833-A1 Gene targeting Pending 01-Jun-2018
EP-3575396-A1 Gene targeting Inactive 01-Jun-2018
EP-3575402-A1 Gene targeting Inactive 01-Jun-2018 C12N9/22
To view Algentech’s complete patent history, request access »

Algentech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Algentech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Scientipole Capital Venture Capital Minority
Investisseurs privés Corporation Minority
Auriga Partners (Paris) Venture Capital Minority
To view Algentech’s complete investors history, request access »

Ready to get started?

Request a free trial

Algentech FAQs

  • When was Algentech founded?

    Algentech was founded in 2009.

  • Where is Algentech headquartered?

    Algentech is headquartered in Evry, France.

  • What is the size of Algentech?

    Algentech has 7 total employees.

  • What industry is Algentech in?

    Algentech’s primary industry is Biotechnology.

  • Is Algentech a private or public company?

    Algentech is a Private company.

  • What is Algentech’s current revenue?

    The current revenue for Algentech is .

  • How much funding has Algentech raised over time?

    Algentech has raised $2.33M.

  • Who are Algentech’s investors?

    , Scientipole Capital, Investisseurs privés, and Auriga Partners (Paris) have invested in Algentech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »